Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.53% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.89% |
| 4 | Industrials | 3.6% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
PUT
Goldman Sachs
GS
$301B
| $222M | 0.11% |
1,156,600
+62,000
| +6% | +$12M |
|
127
CALL
VanEck Semiconductor ETF
SMH
$70.6B
| $222M | 0.11% |
4,169,000
-2,343,800
| -36% | -$116M |
|
128
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $222M | 0.11% |
2,447,900
+140,100
| +6% | +$11.9M |
|
129
Visa
V
$677B
| $219M | 0.11% |
1,403,547
-485,253
| -26% | -$69.9M |
|
130
Dollar Tree
DLTR
$24.6B
| $219M | 0.11% |
2,082,846
+210,967
| +11% | +$20.7M |
|
|
XYZ
131
PUT
Block Inc
XYZ
$47.5B
| $217M | 0.11% |
2,898,400
-74,300
| -2% | -$5.38M |
|
132
CALL
United Parcel Service
UPS
$88.8B
| $217M | 0.11% |
1,939,500
+1,080,700
| +126% | +$115M |
|
133
Mastercard
MA
$492B
| $216M | 0.11% |
917,319
+876,058
| +2,123% | +$188M |
|
134
PUT
Johnson & Johnson
JNJ
$626B
| $213M | 0.11% |
1,527,200
+383,400
| +34% | +$51.4M |
|
135
Toronto Dominion Bank
TD
$201B
| $211M | 0.11% |
3,888,678
+2,512,159
| +183% | +$139M |
|
136
PUT
PayPal
PYPL
$50.5B
| $210M | 0.1% |
2,025,200
-135,400
| -6% | -$12.8M |
|
137
CALL
IBM
IBM
$225B
| $209M | 0.1% |
1,552,369
-104,181
| -6% | -$13.3M |
|
138
CALL
iShares MSCI Brazil ETF
EWZ
$8.6B
| $206M | 0.1% |
5,037,300
+1,708,100
| +51% | +$73.4M |
|
139
Zimmer Biomet
ZBH
$18.5B
| $204M | 0.1% |
1,648,609
+1,645,020
| +45,835% | +$187M |
|
140
CME Group
CME
$93.2B
| $204M | 0.1% |
1,239,848
+713,133
| +135% | +$126M |
|
141
PUT
Citigroup
C
$228B
| $204M | 0.1% |
3,274,800
+93,100
| +3% | +$5.78M |
|
142
PUT
Amgen
AMGN
$224B
| $204M | 0.1% |
1,071,600
+279,500
| +35% | +$53.4M |
|
143
CALL
Bank of America
BAC
$448B
| $202M | 0.1% |
7,338,700
-6,643,800
| -48% | -$188M |
|
144
United Airlines
UAL
$41B
| $202M | 0.1% |
2,530,637
+996,434
| +65% | +$84.1M |
|
|
MRSH
145
Marsh
MRSH
$91.3B
| $201M | 0.1% |
2,141,342
+851,235
| +66% | +$75.3M |
|
146
PUT
Qualcomm
QCOM
$171B
| $201M | 0.1% |
3,525,600
+1,762,600
| +100% | +$95.1M |
|
147
Procter & Gamble
PG
$338B
| $201M | 0.1% |
1,929,445
+538,181
| +39% | +$52.4M |
|
|
148
CALL
Procter & Gamble
PG
$338B
| $201M | 0.1% |
1,927,000
+589,800
| +44% | +$57.4M |
|
149
Thermo Fisher Scientific
TMO
$224B
| $200M | 0.1% |
729,227
+502,851
| +222% | +$125M |
|
150
Costco
COST
$419B
| $199M | 0.1% |
823,515
+484,164
| +143% | +$106M |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,252 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.